Business Description
Pharmadrug Inc
NAICS : 325411
SIC : 3741
ISIN : CA5134413031
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -2.13 | |||||
Debt-to-Equity | -0.06 | |||||
Debt-to-EBITDA | 1.01 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 52.8 | |||||
3-Year EPS without NRI Growth Rate | 53.6 | |||||
3-Year FCF Growth Rate | 42.4 | |||||
3-Year Book Growth Rate | -11.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.31 | |||||
9-Day RSI | 48.77 | |||||
14-Day RSI | 47.06 | |||||
6-1 Month Momentum % | -7.33 | |||||
12-1 Month Momentum % | -15.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -62.2 | |||||
Shareholder Yield % | -13.98 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -76.58 | |||||
ROA % | -12.24 | |||||
ROIC % | -8.44 | |||||
ROC (Joel Greenblatt) % | 108.97 | |||||
ROCE % | 16 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Free-Cash-Flow | 0.74 | |||||
Price-to-Operating-Cash-Flow | 0.74 | |||||
EV-to-EBIT | 3.04 | |||||
EV-to-EBITDA | 3.04 | |||||
EV-to-FCF | 1.95 | |||||
Earnings Yield (Greenblatt) % | 32.93 | |||||
FCF Yield % | 74.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharmadrug Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.029 | ||
Beta | -2.58 | ||
Volatility % | 554.95 | ||
14-Day RSI | 47.06 | ||
14-Day ATR (€) | 0.0034 | ||
20-Day SMA (€) | 0.016295 | ||
12-1 Month Momentum % | -15.71 | ||
52-Week Range (€) | 0.003499 - 0.080499 | ||
Shares Outstanding (Mil) | 93.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmadrug Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmadrug Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Pharmadrug Inc Frequently Asked Questions
What is Pharmadrug Inc(FRA:G11)'s stock price today?
When is next earnings date of Pharmadrug Inc(FRA:G11)?
Does Pharmadrug Inc(FRA:G11) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |